CYP3A4 mediated in vitro metabolism of vinflunine in human liver microsomes

被引:0
|
作者
Xiao-ping ZHAO Jiao ZHONG Xiao-quan LIU~2 Guang-ji WANG Key Laboratory of Drug Metabolism and Pharmacokinetics
机构
关键词
vinflunine; metabolism; CYP3A4; liver microsomes;
D O I
暂无
中图分类号
R96 [药理学];
学科分类号
100602 ; 100706 ;
摘要
Aim:To study the metabolism of vinflunine and the effects of selective cyto-chrome P-450(CYP450)inhibitors on the metabolism of vinflunine in human livermicrosomes.Methods:Individual selective CYP450 inhibitors were used to inves-tigate their effects on the metabolism of vinflunine and the principal CYP450 isoforminvolved in the formation of metabolites M1and M2in human liver microsomes.Results:Vinflunine was rapidly metabolized to 2 metabolites:M1and M2in humanliver microsomes.M1and M2were tentatively presumed to be the N-oxide metabo-lite or hydroxylated metabolite and epoxide metabolite of vinflunine,respectively.Ketoconazole uncompetitively inhibited the formation of M1,and competitivelyinhibited the formation of M2,while α-naphthoflavone,sulfaphenazole,diethyldithiocarbamate,tranylcypromine and quinidine bad little or no inhibitory effecton the formation of M1and M2.Conclusion:Vinflunine is rapidly metabolized inhuman liver microsomes,and CYP3A4 is the major human CYP450 involved in themetabolism of vinflunine.
引用
收藏
页码:118 / 124
页数:7
相关论文
共 50 条
  • [21] In-vitro metabolism of triazolam by human liver microsomes: Role of CYP 3A4 and CYP 3A5.
    Patki, KC
    Von Moltke, LL
    Greenblatt, DJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P95 - P95
  • [22] Metabolic Activation of Strychnine to Reactive Intermediates by Human Liver Microsomes and CYP3A4
    Mao, Yuxi
    Fang, Zhong-Ze
    Ge, Guang-Bo
    Yang, Ling
    DRUG METABOLISM REVIEWS, 2010, 42 : 229 - 230
  • [23] Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomes
    Baumhäkel, M
    Kasel, D
    Rao-Schymanski, RA
    Böcker, R
    Beckurts, KT
    Zaigler, M
    Barthold, D
    Fuhr, U
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2001, 39 (12) : 517 - 528
  • [24] Time-dependent inhibition of CYP3A4 by mibefradil in recombinant CYP3A4 and human liver microsomes and impact on in vivo predictions
    Burt, Howard
    Galetin, Aleksandra
    Houston, Brian
    DRUG METABOLISM REVIEWS, 2006, 38 : 47 - 48
  • [25] In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes P450: Role of CYP3A4 and CYP3A5
    Patki, KC
    von Moltke, LL
    Greenblatt, DJ
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (07) : 938 - 944
  • [26] Effects of deployment-related chemicals on metabolism of estradiol by human liver microsomes, CYP3A4, and CYP1A2
    Usmani, KA
    Rose, RL
    Hodgson, E
    DRUG METABOLISM REVIEWS, 2004, 36 : 156 - 156
  • [27] Utilization of human liver microsomes to explain individual differences in paclitaxel metabolism by CYP2C8 and CYP3A4
    Taniguchi, R
    Kumai, T
    Matsumoto, N
    Watanabe, M
    Kamio, K
    Suzuki, S
    Kobayashi, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 (01) : 83 - 90
  • [28] Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes
    Nakamura, H
    Nakasa, H
    Ishii, I
    Ariyoshi, N
    Igarashi, T
    Ohmori, S
    Kitada, M
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (05) : 534 - 540
  • [29] In vitro metabolism of resveratrol by human liver microsomes and human CYP isoforms
    Piver, B
    Fer, M
    Dréano, Y
    Berthou, F
    DRUG METABOLISM REVIEWS, 2003, 35 : 32 - 32
  • [30] Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes
    Natsui, Kiyohi
    Mizuno, Yoshiko
    Tani, Naoko
    Yabuki, Masashi
    Komuro, Setsuko
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2007, 32 (04) : 233 - 240